Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.01 (+7.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Cash from Financing Activities (2010 - 2025)

Updated

Sangamo Therapeutics' Cash from Financing Activities was $14.8 million in Q4 2025, up 111.7% from $6.99 million a year earlier but down 22.9% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Cash from Financing Activities (2010 - 2025) Analysis & Trends

For FY2025, Cash from Financing Activities at Sangamo Therapeutics came in at $70.75 million, up 149.3% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $28.38 million in FY2024 (+94.5%), $14.59 million in FY2023 (-82.8%), $84.66 million in FY2022 (+157.7%) and $32.86 million in FY2021 (-78.5%).
  • Quarterly Cash from Financing Activities has moved between -$1.57 million (Q1 2022) and $43.82 million (Q3 2022) over five years.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q4 2022 (growth of 825.0%); the worst was Q4 2023 (a decline of 99.1%).
  • Per Business Quant data, SGMOQ's Cash from Financing Activities in the three quarters before Q4 2025 was $19.2 million (Q3 2025), $28.61 million (Q2 2025) and $8.13 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn - 14.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14.80 Mn
Sep 30, 2025 19.20 Mn
Jun 30, 2025 28.61 Mn
Mar 31, 2025 8.13 Mn
Dec 31, 2024 6.99 Mn
Sep 30, 2024 -203,000.00
Jun 30, 2024 -533,000.00
Mar 31, 2024 22.12 Mn
Dec 31, 2023 167,000.00
Sep 30, 2023 -100,000.00
Jun 30, 2023 6.52 Mn
Mar 31, 2023 8.00 Mn
Dec 31, 2022 19.54 Mn
Sep 30, 2022 43.82 Mn
Jun 30, 2022 22.87 Mn
Mar 31, 2022 -1.57 Mn
Dec 31, 2021 2.11 Mn
Sep 30, 2021 5.49 Mn
Jun 30, 2021 10.02 Mn
Mar 31, 2021 15.24 Mn
API Access

Sangamo Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY